Findings from a placebo-controlled, dose-ranging study of Remicade 3mg/kg and 5mg/kg, showed that every eight-week maintenance therapy resulted in greater long-term skin clearance compared with ‘as-needed’ therapy regimens
The study was a phase IV, multicenter, open-label, randomized study evaluating the long-term efficacy of a lower dosage of Soriatane in 77 psoriasis patients. Patients were randomized to
These studies demonstrated that AN0128 was well tolerated at the site of application and indicated that further study was warranted. “While atopic dermatitis is fundamentally a disease of
The new data was presented at the American Academy of Dermatology (AAD) annual meeting. This is the first study of its kind to show the benefit of administering
The study, which is based on a special protocol assessment issued by the FDA, is evaluating the safety and efficacy of Fampridine-SR in improving walking ability in people
The company is seeking approval to market Revlimid in combination with dexamethasone in a proposed indication for the treatment of multiple myeloma patients who have received at least
The compounds are analogs of Novartis’ Ritalin, used for treatment of ADHD and designed specifically to take effect slowly but last longer, thus reducing their potential for abuse
Nastech’s stock fell by 37% following the end of its partnership with Merck. The companies had been collaborating on the development of nasal spray, PYY3-36 (PYY), for the
Designed to inhibit the function of the epidermal growth factor receptor (EGFR) – a molecular structure linked to tumor growth – Erbitux is the first and only monoclonal
This clinical trial will assess the objective response rate and evaluate the pharmacokinetics and safety and tolerability of KRX-0401 (perifosine) as a single agent in relapsed or refractory
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.